Sunosi
Chemical Name | solriamfetol |
Dosage Form | Tablet (oral; 75 mg, 150 mg) |
Drug Class | Inhibitors |
System | Nervous |
Company | Jazz Pharmaceuticals Inc. |
Approval Year | 2019 |
Indication
- Sunosi is indicated to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA).